| Literature DB >> 25856427 |
Maria E Nilsson1, Liesbeth Vandenput1, Åsa Tivesten1, Anna-Karin Norlén1, Marie K Lagerquist1, Sara H Windahl1, Anna E Börjesson1, Helen H Farman1, Matti Poutanen1, Anna Benrick1, Manuel Maliqueo1, Elisabet Stener-Victorin1, Henrik Ryberg1, Claes Ohlsson1.
Abstract
Accurate measurement of sex steroid concentrations in rodent serum is essential to evaluate mouse and rat models for sex steroid-related disorders. The aim of the present study was to develop a sensitive and specific gas chromatography-tandem mass spectrometry (GC-MS/MS) method to assess a comprehensive sex steroid profile in rodent serum. A major effort was invested in reaching an exceptionally high sensitivity for measuring serum estradiol concentrations. We established a GC-MS/MS assay with a lower limit of detection for estradiol, estrone, T, DHT, progesterone, androstenedione, and dehydroepiandrosterone of 0.3, 0.5, 4.0, 1.6, 8, 4.0, and 50 pg/mL, respectively, whereas the corresponding values for the lower limit of quantification were 0.5, 0.5, 8, 2.5, 74, 12, and 400 pg/mL, respectively. Calibration curves were linear, intra- and interassay coefficients of variation were low, and accuracy was excellent for all analytes. The established assay was used to accurately measure a comprehensive sex steroid profile in female rats and mice according to estrous cycle phase. In addition, we characterized the impact of age, sex, gonadectomy, and estradiol treatment on serum concentrations of these sex hormones in mice. In conclusion, we have established a highly sensitive and specific GC-MS/MS method to assess a comprehensive sex steroid profile in rodent serum in a single run. This GC-MS/MS assay has, to the best of our knowledge, the best detectability reported for estradiol. Our method therefore represents an ideal tool to characterize sex steroid metabolism in a variety of sex steroid-related rodent models and in human samples with low estradiol levels.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25856427 DOI: 10.1210/en.2014-1890
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736